EDITAS MEDICINE, INC. (EDIT) Total liabilities 2016–2025
EDITAS MEDICINE, INC. (EDIT) total liabilities at each fiscal year-end, per SEC filings.
$159.2MFY2025 · since FY2016: $94.6M → $159.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $159.2M | -23.2% |
| FY2024 | $207.3M | +38.2% |
| FY2023 | $150.1M | -2.3% |
| FY2022 | $153.6M | +24.1% |
| FY2021 | $123.8M | -30.8% |
| FY2020 | $179.0M | -27.4% |
| FY2019 | $246.4M | +33.8% |
| FY2018 | $184.2M | +11.5% |
| FY2017 | $165.2M | +74.7% |
| FY2016 | $94.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More EDIT financial trends
EDIT RevenueEDIT Net incomeEDIT Net marginEDIT Gross profitEDIT Gross marginEDIT Operating incomeEDIT Operating marginEDIT Operating cash flowEDIT Free cash flowEDIT Capital expendituresEDIT Return on equityEDIT Stock buybacksEDIT Dividends paidEDIT Total assetsEDIT Shareholders’ equityEDIT overview →